(TILs) - ,? -

Kristijan Skok1, Konstantin Bräutigam2

  • 1Diagnostic and Research Institute of Pathology, Medical University of Graz, Stiftingtalstraße 6, Graz 8010, Austria; Institute of Biomedical Sciences, Faculty of Medicine, University of Maribor, Taborska Ulica 8, Maribor 2000, Slovenia.

PubMed
概括

大多数病理学家不经常评估瘤透淋巴细胞 (TILs),尽管它们在癌症免疫治疗中的重要性. 实施中的挑战和对基于人工智能的量化偏好凸显了对人工智能工具和共识指南的需求.